Unraveling the complex behavior of healthy and disease podocytes by analyzing the changes in their unique arrangement of foot processes, slit diaphragm, and the three-dimensional (3D) morphology is a long-standing goal in kidney–glomerular research. The complexities surrounding the podocytes' accessibility in animal models and growing evidence of differences between humans and animal systems have compelled researchers to look for alternate approaches to study podocyte behaviors. With the advent of bioengineered models, an increasingly powerful and diverse set of tools is available to develop novel podocyte culture systems. This review discusses the pertinence of various culture models of podocytes to study podocyte mechanisms in both normal physiology and disease conditions. While no one in vitro system comprehensively recapitulates podocytes' in vivo architecture, we emphasize how the existing systems can be exploited to answer targeted questions on podocyte structure and function. We highlight the distinct advantages and limitations of using these models to study podocyte behaviors and screen therapeutics. Finally, we discuss various considerations and potential engineering strategies for developing next-generation complex 3D culture models for studying podocyte behaviors in vitro.
Impact Statement
In various glomerular kidney diseases, there are numerous alterations in podocyte structure and function. Yet, many of these disease events and the required targeted therapies remain unknown, resulting in nonspecific treatments. The scientific and clinical communities actively search for new modes to develop structurally and functionally relevant podocyte culture systems to gain insights into various diseases and develop therapeutics. Current in vitro systems help in some ways but are not sufficient. A deeper understanding of these previous approaches is essential to advance the field, and importantly, bioengineering strategies can contribute a unique toolbox to establish next-generation podocyte systems.
Get full access to this article
View all access options for this article.
References
1.
EdmonstonD.L., RoeM.T., BlockG., et al.Drug development in kidney disease: proceedings from a multistakeholder conference. Am J Kidney Dis, 76, 842, 2020.
2.
ProgressM., KaskelF.J., FalkR.J., et al.Focal segmental glomerulosclerosis. N Engl J Med, 365, 2398, 2011.
3.
BeckerG.J., and HewitsonT.D.Animal models of chronic kidney disease: useful but not perfect. Nephrol Dial Transplant, 28, 2432, 2013.
4.
YangH.-C., ZuoY., and FogoA.B.Models of chronic kidney disease. Drug Discov Today Dis Model, 7, 13, 2010.
5.
GenoveseG., FriedmanD.J., RossM.D., et al.Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science, 329, 841, 2010.
6.
AndrewsP.M.Investigations of cytoplasmic contractile and cytoskeletal elements in the kidney glomerulus. Kidney Int, 20, 549, 1981.
7.
ShanklandS.J., PippinJ.W., ReiserJ., and MundelP.Podocytes in culture: past, present, and future. Kidney Int, 72, 26, 2007.
8.
BenamK.H., DauthS., HassellB., et al.Engineered in vitro disease models. Annu Rev Pathol Mech Dis, 10, 195, 2015.
9.
RimannM., and Graf-HausnerU.Synthetic 3D multicellular systems for drug development. Curr Opin Biotechnol, 23, 803, 2012.
10.
BreslinS., and O'DriscollL.Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today, 18, 240, 2013.
11.
Romero-GuevaraR., IoannidesA., and XinarisC.Kidney organoids as disease models: strengths, weaknesses and perspectives. Front Physiol, 11, 1, 2020.
12.
RooneyK.M., WoolfA.S., and KimberS.J.Towards modelling genetic kidney diseases with human pluripotent stem cells. Nephron, 145, 285, 2021.
13.
VaughanM.R., and QuagginS.E.How do mesangial and endothelial cells form the glomerular tuft? J Am Soc Nephrol, 19, 24, 2008.
14.
HaraldssonB., NystromJ., and DeenW.M.Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev, 88, 451, 2008.
15.
GargP.A review of podocyte biology. Am J Nephrol, 47, 3, 2018.
16.
QuagginS.E., and KreidbergJ.A.Development of the renal glomerulus: good neighbors and good fences. Development, 135, 609, 2008.
17.
KikkawaY., VirtanenI., and MinerJ.H.Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin α5 in the glomerular basement membrane. J Cell Biol, 161, 187, 2003.
18.
LindahlP., HellströmM., KalénM., et al.Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development, 125, 3313, 1998.
19.
SiegeristF., RibbackS., DombrowskiF., et al.Structured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement. Sci Rep, 7, 1, 2017.
20.
SiegeristF., EndlichK., and EndlichN.Novel microscopic techniques for podocyte research. Front Endocrinol (Lausanne), 9, 1, 2018.
21.
LittleM., GeorgasK., PennisiD., and WilkinsonL.Kidney development: two tales of tubulogenesis. Curr Top Dev Biol, 90, 193, 2010.
22.
FanosV., LoddoC., PudduM., et al.From ureteric bud to the first glomeruli: genes, mediators, kidney alterations. Int Urol Nephrol, 47, 109, 2015.
23.
PericoL., ContiS., BenigniA., and RemuzziG.Podocyte-actin dynamics in health and disease. Nat Rev Nephrol, 12, 692, 2016.
24.
SubramanianB., SunH., YanP., et al.Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury. Kidney Int, 90, 363, 2016.
25.
AngelottiM.L., AntonelliG., ConteC., and RomagnaniP.Imaging the kidney: from light to super-resolution microscopy. Nephrol Dial Transplant, 36, 19, 2021.
26.
BrählerS., YuH., SuleimanH., et al.Intravital and kidney slice imaging of podocyte membrane dynamics. J Am Soc Nephrol, 27, 3285, 2016.
27.
TakasatoM., ErP.X., ChiuH.S., et al.Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature, 526, 564, 2015.
28.
TakasatoM., ErP.X., ChiuH.S., and LittleM.H.Generation of kidney organoids from human pluripotent stem cells. Nat Protoc, 11, 1681, 2016.
29.
HillN., MichellD.L., Ramirez-SolanoM., et al.Glomerular endothelial derived vesicles mediate podocyte dysfunction: a potential role for miRNA. PLoS One, 15, 1, 2020.
30.
HirschbergR., WangS., and MituG.M.Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res, 331, 485, 2008.
31.
SlaterS.C., BeachleyV., HayesT., et al.An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane. PLoS One, 6, e20802, 2011.
32.
CasalenaG.A., YuL., GilR., et al.The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes. Cell Commun Signal, 18, 1, 2020.
33.
SubramanianB., KayaO., PollakM.R., YaoG., and ZhouJ.Guided tissue organization and disease modeling in a kidney tubule array. Biomaterials, 183, 295, 2018.
34.
RonA., AzelogluE.U., CalizoR.C., et al.Cell shape information is transduced through tension-independent mechanisms. Nat Commun, 8, 2145, 2017.
35.
KoroljA., LaschingerC., JamesC., et al.Curvature facilitates podocyte culture in a biomimetic platform. Lab Chip, 18, 3112, 2018.
36.
HomanK.A., KoleskyD.B., Skylar-ScottM.A., et al.Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci Rep, 6, 1, 2016.
37.
KothaS.S., HayesB.J., PhongK.T., et al.Engineering a multicellular vascular niche to model hematopoietic cell trafficking. Stem Cell Res Ther, 9, 1, 2018.
38.
RaynerS.G., HowardC.C., MandryckyC.J., et al.Multiphoton-guided creation of complex organ-specific microvasculature. Adv Healthc Mater, 10, 1, 2021.
39.
AzizgolshaniH., CoppetaJ.R., VedulaE.M., et al.High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows. Lab Chip, 21, 1454, 2021.
40.
MusahS., MammotoA., FerranteT.C., et al.Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip. Nat Biomed Eng, 1, 0069, 2017.
41.
IshahakM., HillJ., AminQ., et al.Modular microphysiological system for modeling of biologic barrier function. Front Bioeng Biotechnol, 8, 1, 2020.
42.
XieR., XieR., KoroljA., et al.H-FIBER: microfluidic topographical hollow fiber for studies of glomerular filtration barrier. ACS Cent Sci, 6, 903, 2020.
43.
WangL., TaoT., SuW., YuH., YuY., and QinJ.A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice. Lab Chip, 17, 1749, 2017.
44.
PetrosyanA., CravediP., VillaniV., et al.A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier. Nat Commun, 10, 3656, 2019.
45.
SaleemM.A., O'HareM.J., ReiserJ., et al.A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol, 13, 630, 2002.
46.
ChunJ., ZhangJ.Y., WilkinsM.S., et al.Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity. Proc Natl Acad Sci U S A, 116, 3712, 2019.
47.
PaquetD., KwartD., ChenA., et al.Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature, 533, 125, 2016.
48.
FreedmanB.S., BrooksC.R., LamA.Q., et al.Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun, 6, 1, 2015.
49.
SharminS., TaguchiA., KakuY., et al.Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation. J Am Soc Nephrol, 27, 1778, 2016.
50.
HobeikaL., BaratiM.T., CasterD.J., McLeishK.R., and MerchantM.L.Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruli. Kidney Int, 91, 501, 2017.
51.
MollicaP.A., Booth-CreechE.N., ReidJ.A., et al.3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels. Acta Biomater, 95, 201, 2019.
52.
NagaoR.J., XuJ., LuoP., et al.Decellularized human kidney cortex hydrogels enhance kidney microvascular endothelial cell maturation and quiescence. Tissue Eng Part A, 22, 1140, 2016.
53.
PolacheckW.J., KutysM.L., TefftJ.B., and ChenC.S.Microfabricated blood vessels for modeling the vascular transport barrier. Nat Protoc, 14, 1425, 2019.
54.
MillerJ.S., StevensK.R., YangM.T., et al.Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater, 11, 768, 2012.
55.
LovettM., EngG., KlugeJ.A., CannizzaroC., Vunjak-NovakovicG., and KaplanD.L.Tubular silk scaffolds for small diameter vascular grafts. Organogenesis, 6, 217, 2010.
56.
EreminaV., BaeldeH.J., and QuagginS.E.Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol, 106, 32, 2007.
57.
TuffinJ., BurkeM., RichardsonT., et al.A composite hydrogel scaffold permits self-organization and matrix deposition by cocultured human glomerular cells. Adv Healthc Mater, 8, 1, 2019.
58.
RiccaB.L., VenugopalanG., and FletcherD.A.To pull or be pulled: parsing the multiple modes of mechanotransduction. Curr Opin Cell Biol, 25, 558, 2013.
59.
AbdallahM., MartinM., El TahchiM.R., et al.Influence of hydrolyzed polyacrylamide hydrogel stiffness on podocyte morphology, phenotype, and mechanical properties. ACS Appl Mater Interfaces, 11, 32623, 2019.
60.
RockwoodD.N., PredaR.C., YücelT., WangX., LovettM.L., and KaplanD.L.Materials fabrication from Bombyx mori silk fibroin. Nat Protoc, 6, 1612, 2011.
61.
NguyenD.H.T., StapletonS.C., YangM.T., et al.Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc Natl Acad Sci U S A, 110, 6712, 2013.
